Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that it will showcase a live case demonstration of its breakthrough DESolve® 100 Novolimus Eluting Bioresorbable Coronary Scaffold System at EuroPCR in Paris on Tuesday, May 20th 2014.
from Content Keyword RSS http://ift.tt/T1Ksgr
via IFTTT
from Content Keyword RSS http://ift.tt/T1Ksgr
via IFTTT
No comments:
Post a Comment